Prediction of symptom remission in schizophrenia during inpatient treatment

References

• Alptekin K, Erkoc S, Gogus AK, et al. Disability in schizophrenia: clinical correlates and prediction over 1-year follow-up. Psychiatry Res 2005; 135: 103–111
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM)4th ed. American Psychiatric Association, Washington, DC 1994
   Google Scholar
• Andreasen NC. Standardized remission criteria in schizophrenia. Acta Psychiatr Scand 2006; 113: 8
   Google Scholar
• Andreasen NC, Carpenter WT, Jr, Kane JM, Lasser RA, Marder SR, Weinberger DR. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry 2005; 162: 441–449
   PubMed Web of Science ®Google Scholar
• Arndt S, Andreasen NC, Flaum M, Miller D, Nopoulos P. A longidudinal study of symptom dimensions in schizophrenia. Prediction and patterns of change. Arch Gen Psychiatry 1995; 52: 352–360
   PubMed Web of Science ®Google Scholar
• Bland RC, Parker JH, Orn H. Prognostic predictors and outcome. Arch Gen Psychiatry 1978; 35: 72–77
   PubMed Web of Science ®Google Scholar
• Bottlender R, Jäger M, Groll C, Strauss A, Möller HJ. Deficit states in schizophrenia and their association with the length of illness and gender. Eur Arch Psychiatry Clin Neurosci 2001; 251: 272–278
   PubMed Web of Science ®Google Scholar
• Cording C. Conceptual aspects in the development and implementation of basic psychiatric documentation. Psychiatr Prax 1998; 25: 175–178
   PubMedGoogle Scholar
• Corell CU, Malhotra AK, Kaushik S, McMeniman M, Kane JM. Early prediction of antipsychotic response in schizophrenia. Am J Psychiatry 2003; 160: 2063–2065
   PubMedGoogle Scholar
• Crow TJ. Molecular pathology of schizophrenia: more than one disease process?. Br Med J 1980; 280: 66–68
   PubMed Web of Science ®Google Scholar
• Dunayevich E, Sethuraman G, Enerson M, Taylor CC, Lin D. Characteristics of two alternative schizophrenia remission definitions: relationship to clinical and quality of life outcomes. Schizophr Res 2006; 86: 300–308
   PubMed Web of Science ®Google Scholar
• Emsley R, Oosthuizen PP, Kidd M, Koen L, Niehaus DJ, Turner HJ. Remission in early psychosis: rates, predictors, and clinical and functional outcome correlates. Schizophr Res 2007; 89: 129–139
   PubMed Web of Science ®Google Scholar
• Gaebel W. Prediction of response to acute neuroleptic treatment in schizophrenia. Int Clin Psychopharmacol 1996; 11(Suppl 2)47–54
   PubMedGoogle Scholar
• Gaebel W, Pietzcker A. Prospective study of course of illness in schizophrenia: Part II. Prediction of outcome. Schizophr Bull 1978; 13: 299–306
   Google Scholar
• Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56–62
   PubMed Web of Science ®Google Scholar
• Händel M, Bailer J, Bräuner W, Laubenstein D, Rey ER. The prognostic scale by Strauss and Carpenter and its validity. Eur Arch Psychiatry Clin Neurosci 1996; 246: 203–208
   PubMedGoogle Scholar
• Harrow M, Marengo JT. Schizophrenic thought disorder at follow-up: its persistence and prognostic significance. Schizophr Bull 1986; 12: 373–393
   PubMed Web of Science ®Google Scholar
• Ho BC, Nopoulos P, Flaum M, Arndt S, Andreasen NC. Two-year outcome in first episode schizophrenia: predictive value of symptoms for quality of life. Am J Psychiatry 1998; 155: 1196–1201
   PubMed Web of Science ®Google Scholar
• Ho BC, Andreasen NC, Nopoulos P, Arndt S, Magnotta V, Flaum M. Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia. Arch Gen Psychiatry 2003; 60: 585–594
   PubMed Web of Science ®Google Scholar
• Hosmer DW, Lemeshow S. Applied logistic regression2nd ed. Wiley, New York 2000
   Google Scholar
• Jäger M, Bottlender R, Strauss A, Möller HJ. Classification of functional psychoses and its implication for prognosis. Comparison between ICD-10 and DSM-IV. Psychopathology 2004; 37: 110–117
   PubMedGoogle Scholar
• Jäger M, Riedel M, Messer T, et al. Psychopathological characteristics and treatment response of first episode compared with multiple episode schizophrenic disorders. Eur Arch Psychiatry Clin Neurosc 2007; 257: 47–53
   PubMed Web of Science ®Google Scholar
• Jonstone EC, Owens DG, Frith CD, Crow TJ. The relative stability of positive and negative features in chronic schizophrenia. Br J Psychiatry 1987; 150: 60–64
   PubMedGoogle Scholar
• Kay SR. Positive and negative syndromes in schizophrenia: Assessment and research. Clinical and experimental psychiatry monograph No. 5. Brunner/Mazel, New York 1991
   Google Scholar
• Kay SR, Murill LM. Predicting outcome of schizophrenia: significance of symptom profiles and outcome dimensions. Comp Psychiatry 1990; 31: 91–102
   PubMed Web of Science ®Google Scholar
• Kokes RF, Strauss JF, Klorman R. Premorbid adjustment in schizophrenia. Part II. Measuring premorbid adjustment: the instrument and their development. Schizophr Bull 1977; 3: 186–213
   PubMed Web of Science ®Google Scholar
• Lasser RA, Bossie CA, Gharabawi GM, Kane JM. Remission in schizophrenia: results from a 1-year study of long-acting risperidone injection. Schizophr Res 2005; 77: 215–227
   PubMed Web of Science ®Google Scholar
• Lauronen E, Miettunen J, Veijola J, Karhu M, Jones PB, Isohanni M. Outcome and its predictors in schizophrenia within the Northern Finland 1966 Birth Cohort. Eur Psychiatry 2007; 22: 129–136
   PubMed Web of Science ®Google Scholar
• Lenoir ME, Dingemans PMAJ, Schene AH, Linszen DH. Predictors of the early 5-year course of schizophrenia: a path analysis. Schizophr Bull 2005; 31: 781–791
   PubMedGoogle Scholar
• Liddle PF, Barners TRE, Morris D, Haque S. Three syndromes in chronic schizophrenia. Br J Psychiatry 1989; 15(Suppl 7)119–122
   Google Scholar
• Liu Z, Tam WC, Xue Z, Yao S, Wu D. Positive and negative symptom profile schizophrenia and abnormalities in the P300 component of the event-related potential: a longitudinal study. Psychiatry Res 2004; 132: 131–139
   PubMedGoogle Scholar
• Mauri MC, Vita A, Giobbio GM, et al. Prediction of response to haloperidol in schizophrenia: neuroendocrine, neuromorphological and clinical variables. Int Clin Psychopharmacol 1994; 9: 3–7
   PubMedGoogle Scholar
• Möller HJ, Scharl W, v. Zerssen D. Prediction of therapeutic response under acute neuroleptic treatment conditions: results of an empirical study on 243 schizophrenic inpatients. Fortschr Neurol Psychiat 1985; 53: 370–383
   PubMedGoogle Scholar
• Möller HJ, Schmidt-Bode W, v. Zerssen D. Prediction of long-term outcome in schizophrenia by prognostic scales. Schizophr Bull 1986; 12: 225–235
   PubMedGoogle Scholar
• Murphy BM, Burke JG, Bray JC, Walsh D, Kendler KS. An analysis of the clinical features of familial schizophrenia. Acta Psychiatr Scand 1994; 89: 421–427
   PubMed Web of Science ®Google Scholar
• Nasrallah HA, Lasser R. Improving patient outcomes in schizophrenia: achieving remission. J Psychopharmacol 2006; 20(Suppl. 6)57–61
   PubMedGoogle Scholar
• Phillips MR, Zhao Z, Xiong X, Cheng X, Sun G, Wu N. Changes in the positive and negative symptoms of schizophrenic in-patients in China. Br J Psychiatry 1991; 159: 226–231
   PubMedGoogle Scholar
• Remington G, Kapur S. Remission: What's in a name. Am J Psychiatry 2005; 162: 12
   PubMedGoogle Scholar
• Robinson DG, Woerner MG, McMeniman M, Mendelowitz A, Bilder RM. Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder. Am J Psychiatry 2004; 161: 473–479
   PubMed Web of Science ®Google Scholar
• Sethuraman G, Taylor CC, Enerson M, Dunayevich E. A retrospective comparison of cumulative time spent in remission during treatment with olanzapine or risperidone among patients with schizophrenia. Schizophr Res 2005; 79: 337–340
   PubMed Web of Science ®Google Scholar
• Szymanski SR, Cannon TD, Gallacher F, Erwin RJ, Gur RE. Course of treatment response in first-episode and chronic schizophrenia. Am J Psychiatry 1996; 153: 519–525
   PubMed Web of Science ®Google Scholar
• van der Gaag, M, Cuijpers, A, Hoffman, T, , et al. 2006. The five-factor model of the Positive and Negative Syndrome Scale I: confirmatory factor analysis fails to confirm 25 published five-factor solutions. Schizophr Res, DOI: 10.1016/j.schres.2006.04.001.
   Google Scholar
• van Os J, Burn T, Cavallaro R, et al. Standardized remission criteria in schizophrenia. Acta Psychiatr Scand 2006a; 113: 91–95
   PubMed Web of Science ®Google Scholar
• van Os J, Drukker M, a Campo J, Meijer J, Back M, Delespaul P. Validation of remission criteria for schizophrenia. Am J Psychiatry 2006b; 163: 2000–2002
   PubMed Web of Science ®Google Scholar
• Weinstein MC, Fineberg HV. Clinical decision analysis. WB Saunders, Philadelphia, PA 1980
   Google Scholar
• Wieselgren IM, Lindstrom E, Lindstrom LH. Symptoms at index admission as predictor for 1-5 year outcome in schizophrenia. Acta Psychiatr Scand 1995; 94: 311–319
   Google Scholar
• Wölwer W, Buchkremer G, Häfner H, et al. German research network on schizophrenia. Bridging the gap between research and care. Eur Arch Psych Clin Neurosci 2003; 253: 321–329
   PubMed Web of Science ®Google Scholar
• World Health Organisation. The ICD-10 Classification of mental and behavioural disorders. Diagnostic Criteria for Research. WHO, Geneva 1993
   Google Scholar
• Wunderink, L, Nienhuis, FJ, Sytema, S, Wiersma, D. 2006. Predictive validity of proposed remission criteria in first-episode schizophrenic patients responding to antipsychotics. Schizophr Bull, DOI: 10.1093/schbul/sbl015.
   PubMedGoogle Scholar